A startup co-founded by Anne Wojcicki, the wife of Google co-founder Sergey Brin, 23andMe has plans to make the human genome searchable. Brin, along with Google, gave 23andMe $3.9 million as part of a series A in May of 2007.
The company was named after the number of chromosome pairs in humans. They aim to help people understand what their genes mean by indexing them and highlighting significant findings.
23andMe allows its clients/users to study their ancestry, genealogy, and inherited traits. The company also markets to researchers and scientists, for whom they provide neatly categorized and easily searchable data.
One reason the Google investment in 23andMe made sense, was that this company could enable the search giant to index another facet of the world's information. With the Biotech and Health Care industries growing rapidly, 23andMe could help Google get and maintain a market hold in these already multi-billion dollar areas.
Funding Rounds (6) - $111.9MUpdate
The National Institutes of Health (NIH) conducts research on the nature and behavior of living...
Healthcare Venture Capital
Google Ventures is the venture capital investment arm of Google Inc.
Global venture capital firm helping entrepreneurs build transformational businesses across...
Venture capital subsidiary
2606 Bayshore Parkway
Mountain View, CA 94042
ScientificMatch utilizes user's DNA to maximize the chances of finding the right partner for...
GenePartner provides users with a formula to match men and women by analyzing specific genes in...
AIBioTech is a contract research organization providing R&D and clinical testing services to...
Navigenics is a personal genomics company that uses genetic testing to help people determine...
- 09/17/12 -techcrunch.com